載入...
KIT AS A THERAPEUTIC TARGET IN MELANOMA
Recently, genetic alterations activating the receptor tyrosine kinase KIT have been demonstrated in some types of melanoma. KIT mutations can be successfully targeted by approved drugs in other cancers. Emerging evidence suggests that melanomas with KIT activation may also respond to KIT inhibitors...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2831053/ https://ncbi.nlm.nih.gov/pubmed/19847190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2009.334 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|